These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia. Schrader G; Hicks EP J Nerv Ment Dis; 1984 Jul; 172(7):439-41. PubMed ID: 6144722 [TBL] [Abstract][Full Text] [Related]
3. Psychosis during methylphenidate abuse. Spensley J; Rockwell DA N Engl J Med; 1972 Apr; 286(16):880-1. PubMed ID: 5061074 [No Abstract] [Full Text] [Related]
4. Confusional paranoid psychosis after withdrawal from sympathomimetic amines: two case reports. Deveaugh-Geiss J; Pandurangi A Am J Psychiatry; 1982 Sep; 139(9):1190-1. PubMed ID: 7114316 [TBL] [Abstract][Full Text] [Related]
5. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders]. Aanonsen NO Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094 [TBL] [Abstract][Full Text] [Related]
6. Amphetamines, barbiturates, LSD and cannabis: their use and misuse. Rep Public Health Med Subj (Lond); 1970; 124():1-75. PubMed ID: 5527004 [No Abstract] [Full Text] [Related]
7. Occurrence of neuroleptic malignant syndrome in a narcoleptic patient. Chayasirisobhon S; Cullis P; Veeramasuneni RR Hosp Community Psychiatry; 1983 Jun; 34(6):548-50. PubMed ID: 6134661 [No Abstract] [Full Text] [Related]
8. [Acute paranoid psychosis as a result of dexamethasone withdrawal]. Vitas B; Jakovljević M; Vitas M; Car N Lijec Vjesn; 1988; 110(3-4):94-6. PubMed ID: 3398692 [No Abstract] [Full Text] [Related]
10. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children. Eisenberg L Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174 [No Abstract] [Full Text] [Related]
11. Amphetamine-type drugs for hyperactive children. Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553 [No Abstract] [Full Text] [Related]
12. [Paranoid-hallucinatory psychosis following chronic abuse of Sedafamen]. Otto KR Psychiatr Neurol Med Psychol (Leipz); 1973 Apr; 25(4):245-9. PubMed ID: 4741759 [No Abstract] [Full Text] [Related]
13. Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association. Sleep; 1994 Jun; 17(4):348-51. PubMed ID: 7973320 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of treatment with stimulants in narcolepsy. Mitler MM Sleep; 1994 Dec; 17(8 Suppl):S103-6. PubMed ID: 7701190 [TBL] [Abstract][Full Text] [Related]
16. [A paranoid syndrome after discontinuing tuberculostatics]. Müller N; Günther W; Müller-Felber W Dtsch Med Wochenschr; 1991 Dec; 116(50):1934. PubMed ID: 1748074 [No Abstract] [Full Text] [Related]
17. Atypical withdrawal syndrome due to propoxyphene. Bikadoroff S; Cusimano M Isr J Psychiatry Relat Sci; 1986; 23(2):157-9. PubMed ID: 3804694 [No Abstract] [Full Text] [Related]
18. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325 [TBL] [Abstract][Full Text] [Related]